Does OLAPARIB Cause Neuropathy peripheral? 411 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 411 reports of Neuropathy peripheral have been filed in association with OLAPARIB (Lynparza). This represents 2.3% of all adverse event reports for OLAPARIB.
411
Reports of Neuropathy peripheral with OLAPARIB
2.3%
of all OLAPARIB reports
13
Deaths
38
Hospitalizations
How Dangerous Is Neuropathy peripheral From OLAPARIB?
Of the 411 reports, 13 (3.2%) resulted in death, 38 (9.2%) required hospitalization, and 8 (1.9%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 411 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which OLAPARIB Alternatives Have Lower Neuropathy peripheral Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL